Not if you attend the Max International 2008 Convention, September 25-27! Our theme, "Imagine," will show you how flights of impossible imagination are coming true with Max. Who could have dreamed that increased energy and health would soar with MaxGXL and MaxWLX and the opportunity for financial freedom would take flight with Max International?

Are you ready to imagine your fabulous future with Max? Join us at our second annual convention and celebrate the exploding growth of Max International that our three Founders dared to imagine possible! Meet those wonderful Founders, Max Corporate Executives and Max Top Leaders. Imagine how much your business will grow when you walk away with the greatest training imaginable! Attendance is limited and we sold out in record time last year.

In 1994, Dr. Robert H. Keller founded The BIODORON Institute of Advanced Medicine, a state-of-the-art medical clinic specializing in cutting edge treatment for immune system disorders and anti-aging.

After reviewing subject lab results for years, Dr. Keller noticed a trend. He kept seeing significantly low levels of uric acid in subjects with immune disorders. He decided to explore this finding, and his initial research concluded that uric acid is the last antioxidant at the body's disposal when all the normal antioxidants have been exhausted.

As Dr. Keller has always been a strong advocate of nutrition, he went back in the literature, seeking the answer to one question: If uric acid is the body's last defense, then what is the first? His investigation led him to a substance called glutathione.

Dr. Keller discovered that the most prevalent, powerful and multifunctional antioxidant in the human body, employed by every organ, is reduced glutathione.

Glutathione (GSH) is a small protein produced naturally in our cells if the requisite precursors are present. It functions both as an antioxidant and an antitoxin and is a major defense system against illness and aging. Our glutathione level actually indicates our state of health and can predict longevity. It has been suggested that in the future, GSH levels will be closely monitored. There are over 60,000 medical articles currently published on GSH, yet most health professionals have only a vague idea of its significance. In the near future, the importance of glutathione will be widely recognized.

After learning of the importance of GSH, Dr. Keller needed to test the hypothesis that the levels of GSH in subjects with immune disorders were, in fact, severely diminished. To get a current and accurate gauge of a subject's GSH level, Dr. Keller knew the test must measure GSH inside of lymphocytes (activated cells); however, no such lab test existed.

Using a state-of-the-art medical laboratory, Dr. Keller and his team of scientists developed a proprietary lab test to measure levels of GSH inside the lymphocytes.

The tests confirmed the hypothesis. People who are stressed, aging, lacking sleep, or with any prolonged illness utilize glutathione at an accelerated rate resulting in decreased bodily stores, weakened defenses, and increased risk of illnesses including accelerated aging.

It was clear that the GSH levels needed to be replenished in these subjects. But how? Glutathione is produced naturally from three amino acids: glycine, glutamine, and cysteine. These essential precursors of GSH must be able to make it from the mouth to the gut, then through the cells walls and subsequently the mitochondrial membrane. There lies the challenge.

Unfortunately, we can't raise our body's GSH level with ordinary foods or pure L-glutathione. Even though glutathione is present in many fruits, vegetables and meats, this protein is instantly broken down during digestion into its three amino acids. Cysteine, or N-acetylcysteine (NAC), is the most important of these precursors and is the main limiting factor necessary for the body to manufacture GSH. Alone in the gut after digestion, cysteine is treated as a free radical and rapidly oxidized. Consequently, only a very small percentage reaches our bloodstream and cells.

Furthermore, GSH is always in great demand and is rapidly consumed, so any GSH that is made will be used up quickly making it even more difficult to increase this level.

After years of research and development, Dr. Keller and the Max International scientific team developed MaxGXL, a product that contains the necessary components of glutathione that when absorbed into the body, stimulate the body's own production of glutathione to be used by every cell.

• 1966 - Bachelor of Arts in Biology Master of Science in Biology Fordham University, Bronx, New York
  
• 1970 - Doctor of Medicine (MD) with honors Temple University, Philadelphia, Pennsylvania
  
• 1970-1974 - Internship, Resident and Senior Resident University of Rochester, Rochester, New York
  
• 1974-1976 - Fellow and Senior Fellow Department of Immunology Mayo Clinic, Rochester, Minnesota
  
• 1976 - Master of Science in Immunology Mayo Graduate School of Medicine Rochester, Minnesota

• 2006 Founder, CSO and Director of Medicine KBK Institute of Advanced Medicine Hollywood, Florida


• 2001 Founder, Chairman, CEO & CSO Phoenix BioSciences which has developed a new first in class and first in man viral-host interaction inhibitor for HIV / AIDS


• 1999 Founder, Chairmain,CEO and CSO Vitimmune, Inc Hollywood, Florida


• 1998 Voluntary Adjunct Professor Miller School of Medicine, University of Miami Miami, Florida


• 1996 Chairman and CEO Immune Balance Technologies Hollywood, Florida


• 1994-2006 Director of Medicine & Research BIODORON Medical Center Hollywood, Florida


• 1994-1995 Consultant in Immunology and Hematology Health Professionals, Inc and Center for Special Immunology


• 1992-1995 Director Immune Reconstitution Program Center for Special Immunology


• 1992-1995 Medical Director Center for Special Immunology Miami Beach, Florida


• 1987-1996 President and Medical Director The Wilson Bode Center Fort Lauderdale, Florida


• 1986-1987 Associate Director of Research and Development Coulter Immunology Coulter Electronics, Inc., Hialeah, Florida


• 1982-1986 Medical Director Wilson Bode Center for Hematology and Immunology Research Milwaukee, Wisconsin


• 1982-1986 Clinical Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin


• 1982-1986 Associate Professor Departments of Medicine and Biophysics Medical College of Wisconsin Milwaukee, Wisconsin


• 1982-1986 Clinical Investigator and Staff Physician Zablocki VAMC Milwaukee, Wisconsin


• 1980-1982 Director of Immunology Midwest Children's Cancer Center (Immunology, Flow Cytometry, Transplantation) Chief of Immunology Milwaukee Children's Hospital Milwaukee, Wisconsin


• 1980-1982 Associate Professor Department of Pediatrics (Hematology/Oncology, Immunology) Medical College of Wisconsin Milwaukee, Wisconsin


• 1979-1982 Clinical Associate Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin


• 1978-1980 Research Associate and Staff Physician Research Service Zablocki VAMC Milwaukee, Wisconsin


• 1977-1980 Assistant Professor Department of Medicine (Hematology/Oncology) Medical College of Wisconsin Milwaukee, Wisconsin


• 1977 Consultant And Assistant Professor Department of Immunology Mayo Medical School Dept. of Medicine University of Minnesota


• 1974-1977 Fellow and Senior Research Fellow in Immunology Mayo Clinic Foundation Mayo Graduate School of Medicine Rochester, Minnesota

• 1976-1977 Mayo Clinic, Rochester, Minnesota
  
• 1977-1986 Zablocki VAMC, Milwaukee, Wisconsin
  
• 1977-1986 Milwaukee County Medical Complex, Milwaukee, Wisconsin
  
• 1992-1997 Mount Sinai Medical Center, Miami Beach, Florida
  
• 1992-1999 Cleveland Clinic Hospital, Fort Lauderdale, Florida
  
• 1992-1999 Miami Heart Institute, Miami Beach, Florida
  
• 1997-1999 Palmetto General Hospital, Hialeah, Florida
  
• 1997- 2005 South Shore Hospital, Miami Beach, Florida
  
• 1997- 2005 Memorial Medical Center, Hollywood, Florida
  
• 1992 Broward General Medical Center, Fort Lauderdale, Florida
  
• 1997 Hollywood Medical Center, Hollywood, Florida

• 1967-1969 Health Professions Scholarship Temple University School of Medicine
  


• 1974-1975 Mayo Foundation Research Fellowship Mayo Graduate School of Medicine
• 1975-1978 National Arthritis Foundation Fellowship


• 1978-1981 VA Career Development Award, Research Associate


• 1983-1986 VA Career Development Award, Clinical Investigator

• 1978-1980 Alpha-fetoprotein Immunoregulation in a Model of Murine Lymphoma Veterans Administration Research Principal Investigator - $210,000
  
• 1981-1986 Immunoregulatory Dysfunction in Non-Hodgkin's Lymphoma NIH, NCI Principal Investigator - $430,000
  
• 1982-1986 Immunologic Studies of Environmental Lung Disease NIH (NIAID) Co-Principal Investigator - $525,000
  
• 1983-1986 VA Career Development Award Clinical Investigator - $240,000
  
• 1984-1986 Clinical Applications of Laser Flow Cytometry Principal Investigator NIH (RR Shared Equipment Program) - $105,609
  
• 1984-1987 Immunoregulatory Dysfunction Principal Investigator VA - $245,000
  
• 1985-1986 Monoclonal Antibodies in the Detection of Cervical Carcinoma Co-Principal Investigator Hillman Foundation - $85,000
  
• 1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation - $125,000
  
• 1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation

• 1970 Alpha Omega Alpha Temple University, School of Medicine
  
• 1970 Medical Degree with honors Temple University, School of Medicine
  
• 1979 Superior Performance Award in Research Veterans Administration
  
• 1980 Fellow, American College of Physicians
  
• 1991 Who's Who in Science and Technology
  
• 1994 Who's Who in the World
  
• 1996 Who's Who in Medicine and Science
  
• 1998 HIV Medical Professional of the Year PWAC, Broward County, Florida
  
• 1999 Humanitarian of the Year National Hemophilia Foundation
  
• 2001 2000 Outstanding Scientists of the 21st Century
  
• 2002 1000 Great Americans of the 21st Century
  
• 2003 America's Top Physicians in Internal Medicine, Immunology and Hematology
  
• 2004 Elected to Board of Governors

• 2004 AMA Physicians Recognition Award
  
• 2005 Greatest Scholars of the Twenty First Century
  
• 2006 Health Professional of the Year Invited Lectureships:
  
• 1977 Second Fogarty International Conference on Neonatal Liver Disease Baltimore, Maryland
  
• 1977 International Conference on the Diagnosis and Prevention of Neural Tube Defects Los Angeles, California
  
• 1977 Second International Conference on Diagnostic Immunology Henniker, New Hampshire
  
• 1979 Radio immunochemical Detection of Cancer Albuquerque, New Mexico
  
• 1980 Visiting Professor of Hematology University of Mississippi Jackson, Mississippi
  
• 1981 Visiting Professor of Hematology University of California Irvine, California
  
• 1981 Third International Conference on Diagnostic Immunology, Section Chair
  
• 1982 Visiting Professor of Pathology University of Texas Medical Branch Galveston, Texas
  
• 1983 Visiting Professor of Medicine Wilfred Hall Air Force Research Center Galveston, Texas
  
• 1984 Visiting Professor Max Plank Institute for Biochemie Munich, Germany
  
• 2005 Visiting Professor of Immunology and Pharmacology Peking Union Medical School (University of Beijing) Beijing, China

• 1986-1990 Diagnostic Immunology
  


• 1984-1986 Journal of Leukocyte Biology
  


• 2005 Interventions in Aging
  

• 1990 - Present Journal of Immunology
  


• 2005 Interventions in Aging
  

• Coulter Epics
  


• Coulter Immunology
  


• Corning Scientific
  


• National Aeronautics and Space Administration (NASA)
  


• Abbott HIV Advisory Board
  


• Baxter Advisory Board for Hemophilia
  


• Baxter Advisory Board for Hemophilia Inhibitor Patients
  


• Consultant in Cancer Therapy, PRSS-J, Tokyo, 2005
  


• Medical Advisory Council, American Federation of Hemophilia, 2002
  

• 2006 Member American Academy of HIV Medicine
  


• 2006 Member Biosource Therapeutics
• 2001 Chairman, Phoenix Bioscience


• 1999 Chairman, VitImmune


• 1996 Chairman, IBT

• 2006 Cytodyn Inc
  


• 2006 Acthelon Medical


• 2006 Bioscource Therapeutics

• National Board of Medical Examiners, 1971 and 1990
  


• American Board of Internal Medicine, 1974
  


• American Academy of HIV Medicine, 2001
  


• American Academy of Anti Aging Medicine 2006
  

• New York #112195
  


• Wisconsin #19121
  


• Florida #58991
  

• ACLS 1990
  


• ATLS 1990